General Archive
-
News releases
LifeArc Diagnostics Centre achieves medical device certification within one year of opening
London, UK, 31 August 2018: LifeArc®, one of the UK’s leading medical research charities, proudly announces that its Centre for Diagnostic…
-
News releasesInnovative diagnostic test for tuberculosis could save millions of lives
Lifearc® the medical research charity, and The University of St Andrews Infection Group today announced a partnership to develop a molecular…
-
News releasesLifeArc appoints Head of Seed Funds
David Holbrook has been appointed to manage our newly created Seed Fund. The £25m fund will invest in innovative early…
-
News releases
CEO Dave Tapolczay stepping down
Dave Tapolczay, Chief Executive Officer, LifeArc, has announced his intention to step down after 10 years in the role. Under…
-
News releases
LifeArc announces £5M support for rare disease research
LifeArc®, the medical research charity, today announced its Philanthropic Fund will award £5M in grants to support medical research projects…
-
News releasesNew partnership in artificial intelligence and machine learning for target discovery announced
New LifeArc®/Milner Therapeutics Institute partnership use machine learning to identify and validate new drug targets in immuno-oncology and respiratory diseases.
-
News releasesPartnership with TetraGenetics targets Type 1 diabetes
New partnership hopes to accelerate the development of a cure for Type 1 Diabetes.
-
News releasesLifeArc appointments strengthen board of trustees
LifeArc has strengthened its board by appointing three new trustees.
-
News releases
Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment
A new platform for assessing anti-cancer drug efficacy could expedite the discovery of new cancer therapies.
-
News releases
Timur Avkiran awarded Industrial Fellowship
The Royal Commission for the Exhibition of 1851 has awarded Industrial Fellowships worth up to £80,000 to the UK’s 14…
-
News releasesSpringWorks Therapeutics launched to progress investigational therapies for patients with unmet medical needs
Four therapies could lead to new treatments for desmoid tumours, neurofibromatosis, hereditary xerocystosis and post-traumatic stress disorder.
-
News releasesLifeArc and AUTM forge international partnership to provide training for scholars in technology transfer
We have partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide…